{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:51:48Z","timestamp":1794621108994,"version":"4.9.1"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Melasma is a common acquired disorder of hyperpigmentation, classically manifesting as symmetric brown patches on the face. Although the exact pathogenesis is not fully understood, vascular abnormalities have been implicated in melasma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To evaluate the laboratory and clinical evidence regarding the safety and efficacy of antivascular agents for the treatment of melasma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>A systematic review of PubMed, EMBASE, and Cochrane was conducted on May 13, 2020, using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Original research articles investigating the role of vascularity and\/or evaluating the use of antivascular therapeutics in melasma were included. Clinical recommendations were based on the American College of Physicians guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>A total of 34 original research articles as follows were identified: 4 laboratory studies, 15 diagnostic studies, and 15 therapeutic studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>There is promising evidence supporting the use of tranexamic acid and laser\/light therapies to treat the vascular component of melasma, and more rigorous clinical trials are needed to validate their efficacy. Clinicians may consider treatment with one or more antivascular therapeutics in patients with melasma. Further research is warranted to characterize the role of cutaneous vascularization in melasma and may provide insights for novel therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dss.0000000000002770","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T10:02:27Z","timestamp":1601028147000},"page":"1642-1650","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":26,"title":["The Vascular Component of Melasma: A Systematic Review of Laboratory, Diagnostic, and Therapeutic Evidence"],"prefix":"10.1097","volume":"46","author":[{"given":"Natasha","family":"Masub","sequence":"first","affiliation":[{"name":"Department of Dermatology, State University of New York, Downstate Health Sciences University, Brooklyn, New York;"},{"name":"Dermatology Service, VA New York Harbor Healthcare System\u2014Brooklyn Campus, Brooklyn, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie K.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, State University of New York, Downstate Health Sciences University, Brooklyn, New York;"},{"name":"Dermatology Service, VA New York Harbor Healthcare System\u2014Brooklyn Campus, Brooklyn, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Austin","sequence":"additional","affiliation":[{"name":"Department of Dermatology, State University of New York, Downstate Health Sciences University, Brooklyn, New York;"},{"name":"Dermatology Service, VA New York Harbor Healthcare System\u2014Brooklyn Campus, Brooklyn, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Jagdeo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, State University of New York, Downstate Health Sciences University, Brooklyn, New York;"},{"name":"Dermatology Service, VA New York Harbor Healthcare System\u2014Brooklyn Campus, Brooklyn, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"key":"R1-20260121","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0733-8635(03)00075-5","article-title":"Epidemiology of skin diseases in ethnic populations","volume":"21","author":"Taylor","year":"2003","journal-title":"Dermatol Clin"},{"key":"R2-20260121","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijwd.2017.11.003","article-title":"The effect of melasma on self-esteem: a pilot study","volume":"4","author":"Jiang","year":"2018","journal-title":"Int J Womens Dermatol"},{"key":"R3-20260121","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s40257-019-00488-w","article-title":"Melasma treatment: an evidence-based review","volume":"21","author":"McKesey","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"R4-20260121","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s13555-017-0194-1","article-title":"Melasma: an up-to-date comprehensive review","volume":"7","author":"Ogbechie-Godec","year":"2017","journal-title":"Dermatol Ther"},{"key":"R5-20260121","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1468-3083.2009.03295.x","article-title":"A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma","volume":"23","author":"Ortonne","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R6-20260121","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1468-3083.2011.04430.x","article-title":"Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women","volume":"27","author":"Tamega","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R7-20260121","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.cell.2006.12.045","article-title":"Central role of p53 in the suntan response and pathologic hyperpigmentation","volume":"128","author":"Cui","year":"2007","journal-title":"Cell"},{"key":"R8-20260121","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.0007-0963.2001.04556.x","article-title":"Melasma: histopathological characteristics in 56 Korean patients","volume":"146","author":"Kang","year":"2002","journal-title":"Br J Dermatol"},{"key":"R9-20260121","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.0906-6705.2005.00345.x","article-title":"Modulation of vascular endothelial growth factor receptors in melanocytes","volume":"14","author":"Kim","year":"2005","journal-title":"Exp Dermatol"},{"key":"R10-20260121","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jdermsci.2007.01.009","article-title":"The vascular characteristics of melasma","volume":"46","author":"Kim","year":"2007","journal-title":"J Dermatol Sci"},{"key":"R11-20260121","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/exd.13183","article-title":"Upregulation of protease-activated receptor-2 in keratinocytes by epidermal vascular endothelial growth factor in vitro and in vivo","volume":"26","author":"Lee","year":"2017","journal-title":"Exp Dermatol"},{"key":"R12-20260121","first-page":"S53","article-title":"Involvement of increased protease-activated receptor-2 expression in the pathogenesis of melasma","volume":"130","author":"Lee","year":"2010","journal-title":"J Invest Dermatol"},{"key":"R13-20260121","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1111\/j.1600-0625.2009.01057.x","article-title":"In vivo reflectance confocal microscopy detects pigmentary changes in melasma at a cellular level resolution","volume":"19","author":"Kang","year":"2010","journal-title":"Exp Dermatol"},{"key":"R14-20260121","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5005\/jp-journals-10061-0002","article-title":"Dermoscopic characteristics of melasma in Indians: a cross-sectional study","volume":"1","author":"Neema","year":"2017","journal-title":"Int J Dermoscopy"},{"key":"R15-20260121","first-page":"6","article-title":"Melasma: through the eye of a dermoscope","volume":"2","author":"Manjunath","year":"2016","journal-title":"Int J Res Dermatol"},{"key":"R16-20260121","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4103\/idoj.IDOJ_6_17","article-title":"Dermoscopy of melasma","volume":"8","author":"Sonthalia","year":"2017","journal-title":"Indian Dermatol Online J"},{"key":"R17-20260121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5021\/ad.2018.30.1.1","article-title":"Treatment of melasma with pulsed-dye laser and 1,064-nm Q-switched Nd:YAG laser: a split-face study","volume":"30","author":"Kong","year":"2018","journal-title":"Ann Dermatol"},{"key":"R18-20260121","first-page":"e13300","article-title":"New local treatments for different types of melasma: vascular type vs nonvascular type. A randomized polycentric study","author":"Fioranelli","year":"2020","journal-title":"Dermatol Ther"},{"key":"R19-20260121","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2230.2008.02724.x","article-title":"Solar elastosis and presence of mast cells as key features in the pathogenesis of melasma","volume":"33","author":"Hernandez-Barrera","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"R20-20260121","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1346-8138.2008.00579.x","article-title":"Co-localization of inducible nitric oxide synthase and phosphorylated Akt in the lesional skins of patients with melasma","volume":"36","author":"Jo","year":"2009","journal-title":"J Dermatol"},{"key":"R21-20260121","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/1947601911423031","article-title":"Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies","volume":"2","author":"Shibuya","year":"2011","journal-title":"Genes Cancer"},{"key":"R22-20260121","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1038\/jid.2015.332","article-title":"Endothelial cells promote pigmentation through endothelin receptor B activation","volume":"135","author":"Regazzetti","year":"2015","journal-title":"J Invest Dermatol"},{"key":"R23-20260121","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0749.1997.tb00488.x","article-title":"The role of endothelin-1 in epidermal hyperpigmentation and signaling mechanisms of mitogenesis and melanogenesis","volume":"10","author":"Imokawa","year":"1997","journal-title":"Pigment Cell Res"},{"key":"R24-20260121","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/09546634.2018.1441487","article-title":"Pulsed dye laser versus intense pulsed light in melasma: a split-face comparative study","volume":"29","author":"Hassan","year":"2018","journal-title":"J Dermatol Treat"},{"key":"R25-20260121","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/DSS.0000000000001120","article-title":"The clinical and histological effect of a low-fluence Q-switched 1,064-nm neodymium:yttrium-aluminum-garnet laser for the treatment of melasma and solar lentigenes in Asians: prospective, randomized, and split-face comparative study","volume":"43","author":"Kaminaka","year":"2017","journal-title":"Dermatol Surg"},{"key":"R26-20260121","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/ced.12835","article-title":"Efficacy and possible mechanisms of topical tranexamic acid in melasma","volume":"41","author":"Kim","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"R27-20260121","article-title":"A comparative study between oral tranexamic acid versus oral tranexamic acid and Q-switched Nd-YAG laser in melasma treatment: a clinical and dermoscopic evaluation","author":"Agamia","year":"2020","journal-title":"J Dermatol Treat"},{"key":"R28-20260121","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.6836297","article-title":"Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation","volume":"220","author":"Anderson","year":"1983","journal-title":"Science"},{"key":"R29-20260121","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1001\/archdermatol.2011.255","article-title":"Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study","volume":"147","author":"Passeron","year":"2011","journal-title":"Arch Dermatol"},{"key":"R30-20260121","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1016\/j.jaad.2013.02.022","article-title":"Long-lasting effect of vascular targeted therapy of melasma","volume":"69","author":"Passeron","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R31-20260121","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/lsm.22518","article-title":"Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser","volume":"49","author":"Geddes","year":"2017","journal-title":"Lasers Surg Med"},{"key":"R32-20260121","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5021\/ad.2012.24.3.267","article-title":"Intense pulsed light and low-fluence Q-switched Nd:YAG laser treatment in melasma patients","volume":"24","author":"Na","year":"2012","journal-title":"Ann Dermatol"},{"key":"R33-20260121","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/09546634.2011.646938","article-title":"The degree of erythema in melasma lesion is associated with the severity of disease and the response to the low-fluence Q-switched 1064-nm Nd:YAG laser treatment","volume":"24","author":"Park","year":"2013","journal-title":"J Dermatolog Treat"},{"key":"R34-20260121","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamadermatol.2014.5580","article-title":"Copper bromide laser vs triple-combination cream for the treatment of melasma: a randomized clinical trial","volume":"151","author":"Ghorbel","year":"2015","journal-title":"JAMA Dermatol"},{"key":"R35-20260121","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1524-4725.2010.01564.x","article-title":"Clinicopathologic efficacy of copper bromide plus\/yellow laser (578 nm with 511 nm) for treatment of melasma in Asian patients","volume":"36","author":"Lee","year":"2010","journal-title":"Dermatol Surg"},{"key":"R36-20260121","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1468-3083.2012.04464.x","article-title":"Effect of tranexamic acid on melasma: a clinical trial with histological evaluation","volume":"27","author":"Na","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R37-20260121","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/jocd.12979","article-title":"Whitening effects of cosmetic formulation in the vascular component of skin pigmentation","volume":"19","author":"Pereira","year":"2020","journal-title":"J Cosmet Dermatol"},{"key":"R38-20260121","doi-asserted-by":"crossref","first-page":"903","DOI":"10.7150\/ijms.44188","article-title":"Tranexamic acid inhibits angiogenesis and melanogenesis in vitro by targeting VEGF receptors","volume":"17","author":"Zhu","year":"2020","journal-title":"Int J Med Sci"},{"key":"R39-20260121","doi-asserted-by":"crossref","first-page":"373","DOI":"10.5021\/ad.2010.22.4.373","article-title":"What should be considered in treatment of melasma","volume":"22","author":"Kang","year":"2010","journal-title":"Ann Dermatol"},{"key":"R40-20260121","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/ced.13234","article-title":"The clinicoaetiological, hormonal and histopathological characteristics of melasma in men","volume":"43","author":"Handa","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"R41-20260121","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1468-3083.2010.03638.x","article-title":"Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis","volume":"24","author":"Jang","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R42-20260121","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2340\/00015555-2315","article-title":"Cadherin 11 involved in basement membrane damage and dermal changes in melasma","volume":"96","author":"Kim","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"R43-20260121","first-page":"S106","article-title":"CD4, IL-17, and COX-2 are associated with inflammation in melasma","volume":"135","author":"Rodr\u00edguez-Ar\u00e1mbula","year":"2015","journal-title":"J Invest Dermatol"},{"key":"R44-20260121","first-page":"S94","article-title":"Inflammatory features of melasma lesions in Asian skin","volume":"134","author":"Noh","year":"2014","journal-title":"J Invest Dermatol"},{"key":"R45-20260121","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jaad.2010.10.037","article-title":"The histopathological characteristics of male melasma: comparison with female melasma and lentigo","volume":"66","author":"Jang","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R46-20260121","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/DSS.0000000000000652","article-title":"Long-pulsed dye laser of 595 nm in combination with pigment-specific modalities for a patient exhibiting increased vascularity within lesions of melasma","volume":"42","author":"Geddes","year":"2016","journal-title":"Dermatol Surg"},{"key":"R47-20260121","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/14764172.2014.957217","article-title":"Retrospective analysis of melasma treatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser vs. low-fluence Q-switched Nd:YAG laser monotherapy","volume":"17","author":"Choi","year":"2015","journal-title":"J Cosmet Laser Ther"},{"key":"R48-20260121","first-page":"S1545961619P1156X","article-title":"Topical treatments for melasma: a systematic review of randomized controlled trials","volume":"18","author":"Austin","year":"2019","journal-title":"J Drugs Dermatol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T14:03:04Z","timestamp":1769004184000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000002770","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,22]]}}}